Written by Averil Power, CEO, Irish Cancer Society
A milestone development for the Irish Cancer Society took place during the first half of this year, as they announced their partnership with the Trinity St James’s Cancer Institute to fund new programmes integrating scientific discovery with patient care to pioneer novel ways to prevent, detect and treat cancer – in particular to address the rise in the incidence of gastrointestinal cancers among patients under fifty years of age.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.